drugset / Trial / NCT02706769

Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Pain

NCT02706769 ↗

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

National guidelines advocate the use of paracetamol in conjunction with strong opioids for cancer pain, despite a lack of evidence for its efficacy. Work is needed to examine the analgesic benefit of paracetamol in this large patient group. The investigators aim to establish if paracetamol in combination with strong opioids provides superior analgesia for cancer related pain over strong opioids alone.

Timeline

Start
2016-11-25
Primary completion
2018-09-04
Completion
2019-05

Outcome

Outcome not reported

Stopped (Enrollment): “Funding was terminated early due to slow recruitment.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule — —

Indications

No indication recorded.